You are here: Industry Insights > COVID-19

News List

Pre-existing antibodies may protect some people against COVID-19: Study expresspharma
November 10, 2020
Researchers found that some people, notably children, have antibodies reactive to the novel coronavirus SARS-CoV-2 in their blood, despite not ever having being infected with the virus.
Pfizer, BioNTech COVID-19 Vax Candidate Successful in Phase III Interim Analysis contractpharma
November 10, 2020
mRNA-based vaccine candidate BNT162b2 found to be more than 90% effective in preventing COVID-19.
Vuzix Smart Glasses Enables Continuous Research of Blood Cells and the COVID-19 Virus at Newcastle University prnewswire
November 09, 2020
?Vuzix? Corporation, a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, announced that Newcastle University, a UK public research university, has deployed the Vuzix M400 Smart Glasses to carry out remote support ...
CARE GA Receives Study May Proceed Letter from US FDA to Initiate Phase II Clinical Trial of Senhwa's Silmitasertib in COVID-19 Patients prnewswire
November 09, 2020
Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, announced its clinical partner- Center for Advanced Research and Education (CARE) in ...
COVID-19 Outpatient Trial Demonstrates REGN-COV2 Antibody Cocktail Reduced Virus Levels americanpharmaceuticalreview
November 09, 2020
Regeneron Pharmaceuticals announced positive, prospective results from an ongoing Phase 2/3 seamless trial in the COVID-19 outpatient setting showing its investigational antibody cocktail, REGN-COV2, met the primary and key secondary endpoints.
OncoSec Announces FDA Clearance for Trial of COVID-19 Vaccine Candidate americanpharmaceuticalreview
November 09, 2020
OncoSec Medical announced the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for a first-in-human Phase 1 trial for CORVax12, a novel DNA-encodable vaccine against SARS-CoV-2 that the Company ...
Regeneron to continue patient recruitment for Covid-19 trial pharmaceutical-technology
November 09, 2020
The independent data monitoring committee (DMC) has recommended the continuation of Regeneron’s UK-based RECOVERY trial analysing REGN-COV2 in hospitalised patients with Covid-19.
Celltrion presents data for COVID-19 monoclonal antibody treatment candidate CT-P59 expresspharma
November 09, 2020
It demonstrated promising safety, tolerability, antiviral effect, and efficacy profile of CT-P59 in patients with mild symptoms of COVID-19.
Humanigen announces positive interim data of Lenzilumab in hospitalised COVID-19 patients expresspharma
November 09, 2020
The company intends to file for EUA in the first quarter of 2021 either following interim data at 75 per cent or at study completion.
Trial in Britain to assess aspirin as potential COVID-19 drug expresspharma
November 09, 2020
The scientists behind the RECOVERY trial, which is looking into a range of potential treatments for COVID-19, said it would include the drug, which is commonly used as a blood thinner.